Electromed, Inc. (ELMD) vs RxSight, Inc. (RXST)
Electromed, Inc. and RxSight, Inc. are both Medical Devices companies. Electromed, Inc. is the larger, with a market value of $233.1M against $196.7M — 1.2× the size. RxSight, Inc. has negative trailing earnings, so its P/E is not meaningful; Electromed, Inc. trades at 20.4×. Electromed, Inc. grew revenue faster over the last twelve months: 15.3% against −13.3%. Electromed, Inc. has the higher net margin (15.3% vs −36.8%) and the higher return on invested capital (25.9% vs −63.2%). Across the 19 metrics below, Electromed, Inc. leads on 14 and RxSight, Inc. on 5.
Valuation
Profitability
| Metric | ELMD | RXST | Medical Devices median |
|---|---|---|---|
| Gross margin | 78.54% | 77.50% | 56.01% |
| Operating margin | 18.82% | (43.20%) | (15.03%) |
| Net margin | 15.32% | (36.80%) | (20.40%) |
| Free cash flow margin | 11.34% | (21.29%) | (7.24%) |
| Return on equity | 23.26% | (17.35%) | (15.32%) |
| Return on assets | 18.82% | (14.19%) | (19.72%) |
| Return on invested capital | 25.87% | (63.16%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack